Herstel Nutriscience Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 9 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.93 M
- Revenue Growth 2.31%
- Profit Growth -22.26%
- Ebitda -5.75%
- Net Worth 2.51%
- Total Assets 28.94%
About Herstel Nutriscience
Herstel Nutriscience Private Limited (HNPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 31 July 2015 (Nine years and six months 5 days old ). Its registered office is in Agra, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹2.93 M.
Sushil Kumar and Manorma Singh serve as directors at the Company.
Company Details
-
Location
Agra, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24233UP2015PTC072354
-
Company No.
072354
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
31 Jul 2015
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Herstel Nutriscience?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sushil Kumar
|
Whole-Time Director | 31-Jul-2015 | Current |
|
Manorma Singh
|
Director | 01-Sep-2019 | Current |
Financial Performance of Herstel Nutriscience.
Herstel Nutriscience Private Limited, for the financial year ended 2018, experienced modest growth in revenue, with a 2.31% increase. The company also saw a substantial fall in profitability, with a 22.26% decrease in profit. The company's net worth moved up by a moderate rise of 2.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Herstel Nutriscience?
In 2018, Herstel Nutriscience had a promoter holding of 98.00% and a public holding of 2.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹2.93 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.29 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Jun 2020 | Others | ₹0.43 M | Open |
| 16 Jan 2016 | Others | ₹2.50 M | Open |
How Many Employees Work at Herstel Nutriscience?
Unlock and access historical data on people associated with Herstel Nutriscience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Herstel Nutriscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Herstel Nutriscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
